221 related articles for article (PubMed ID: 6983560)
1. Leukocyte subpopulations elicited by a nontumorigenic variant of B16 melanoma: their role in direct rejection of the melanoma and in prevention of tumorigenesis in Winn assays.
Calvelli TA; Freedman VH; Silverstein SC; Silagi S
J Exp Med; 1982 Dec; 156(6):1723-38. PubMed ID: 6983560
[TBL] [Abstract][Full Text] [Related]
2. Malignant mouse melanoma cells do not form tumors when mixed with cells of a non-malignant subclone: relationships between plasminogen activator expression by the tumor cells and the host's immune response.
Newcomb EW; Silverstein SC; Silagi S
J Cell Physiol; 1978 May; 95(2):169-77. PubMed ID: 306389
[TBL] [Abstract][Full Text] [Related]
3. Macrophages elicited with heat-killed bacillus Calomette-Guérin protect C57BL/6J mice against a syngeneic melanoma.
Freedman VH; Calvelli TA; Silagi S; Silverstein SC
J Exp Med; 1980 Sep; 152(3):657-73. PubMed ID: 6997425
[TBL] [Abstract][Full Text] [Related]
4. Relationship between rejection of several syngeneic tumors and retrovirus production by 5-bromodeoxyuridine-grown melanoma cells: lack of protection in natural killer-deficient beige mice.
Silagi S; Calvelli TA
Cancer Res; 1982 Jul; 42(7):2562-6. PubMed ID: 7083149
[TBL] [Abstract][Full Text] [Related]
5. Destruction of experimental malignant melanoma by mediators of cellular immunity.
Youdim S
Cancer Res; 1977 Feb; 37(2):572-7. PubMed ID: 401681
[TBL] [Abstract][Full Text] [Related]
6. Specific tumoricidal activity of cytotoxic macrophages and cytotoxic lymphocytes.
Dullens HF; Schakenraad S; Oostdijk A; Vuist W; Van der Maas M; Den Otter W
Cancer Immunol Immunother; 1986; 22(2):100-6. PubMed ID: 3487380
[TBL] [Abstract][Full Text] [Related]
7. Co-cultivation of tumorigenic mouse melanoma cells with cells of a non-tumorigenic subclone inhibits plasminogen activator expression by the melanoma cells.
Kyner D; Christman J; Acs G; Silagi S; Newcomb EW; Silverstein SC
J Cell Physiol; 1978 May; 95(2):159-67. PubMed ID: 206566
[TBL] [Abstract][Full Text] [Related]
8. Cellular immune reactivity in vitro and tumor rejection provided by tumor-associated antigens of friend-virus-induced leukemia.
Dean JH; McCoy JL; Law LW; Maurer BA; Appella E
Int J Cancer; 1975 Nov; 16(5):701-12. PubMed ID: 1184239
[TBL] [Abstract][Full Text] [Related]
9. Activation in vitro of mouse macrophages by syngeneic, allogeneic, or xenogeneic lymphocyte supernatants.
Fidler IJ
J Natl Cancer Inst; 1975 Nov; 55(5):1159-63. PubMed ID: 1206741
[TBL] [Abstract][Full Text] [Related]
10. In vitro reactivity of macrophages and lymphocytes from ultraviolet-irradiated mice.
Norbury KC; Kripke ML; Budmen MB
J Natl Cancer Inst; 1977 Oct; 59(4):1231-5. PubMed ID: 903998
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of tumor cell resistance to lysis by syngeneic lymphocytes.
Fidler IJ; Bucana C
Cancer Res; 1977 Nov; 37(11):3945-56. PubMed ID: 908034
[TBL] [Abstract][Full Text] [Related]
12. The role of host lymphocytes and host macrophages in antitumor reactions after injection of sensitized lymphocytes and tumor target cells into naive mice.
Dullens HF; Vuist W; Van der Maas M; Den Otter W
Cancer Immunol Immunother; 1986; 23(2):113-8. PubMed ID: 3536093
[TBL] [Abstract][Full Text] [Related]
13. T lymphocyte-enriched murine peritoneal exudate cells. I. A reliable assay for antigen-induced T lymphocyte proliferation.
Schwartz RH; Jackson L; Paul WE
J Immunol; 1975 Nov; 115(5):1330-8. PubMed ID: 51890
[TBL] [Abstract][Full Text] [Related]
14. Immune reactivity in SL2 lymphoma-bearing mice compared with SL2-immunized mice.
De Weger RA; Wilbrink B; Moberts RM; Mans D; Oskam R; Den Otter W
Cancer Immunol Immunother; 1987; 24(1):25-36. PubMed ID: 3493070
[TBL] [Abstract][Full Text] [Related]
15. Alloantigen-activated lymphocytes from mice bearing a spontaneous "nonimmunogenic" adenocarcinoma inhibit its growth in vivo by recruiting host immunoreactivity.
Giovarelli M; Santoni A; Forni G
J Immunol; 1985 Nov; 135(5):3596-603. PubMed ID: 3930610
[TBL] [Abstract][Full Text] [Related]
16. Antibody-mediated suppression of grafted lymphoma. III. Evaluation of the role of thymic function, non-thymus-derived lymphocytes, macrophages, platelets, and polymorphonuclear leukocytes in syngeneic and allogeneic hosts.
Shin HS; Hayden M; Langley S; Kaliss N; Smith MR
J Immunol; 1975 Apr; 114(4):1255-63. PubMed ID: 1078832
[TBL] [Abstract][Full Text] [Related]
17. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
Brunda MJ; Taramelli D; Holden HT; Varesio L
J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
[TBL] [Abstract][Full Text] [Related]
18. Eradication of tumor cells after injection into immunized hosts compared with the eradication of tumor cells after transfer of immune peritoneal exudates into tumor-bearing recipients.
Den Otter W; De Groot JW; Dullens HF
Cancer Immunol Immunother; 1983; 16(2):72-6. PubMed ID: 6559103
[TBL] [Abstract][Full Text] [Related]
19. The isolation of immunogenic molecular entities from immunogenic and nonimmunogenic tumor homogenates by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE).
Sharon R; Naor D
Cancer Immunol Immunother; 1984; 18(3):203-8. PubMed ID: 6239688
[TBL] [Abstract][Full Text] [Related]
20. Allograft cytotoxicity: critical role for adherent T cells in effector mechanism of the peritoneal population.
Jones B; Penfold P
Cell Immunol; 1979 Sep; 46(2):259-74. PubMed ID: 114306
[No Abstract] [Full Text] [Related]
[Next] [New Search]
